Bank of Montreal
CRDF icon

Bank of Montreal’s Cardiff Oncology CRDF Stock Holding History

Bank of Montreal’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,100
Closed -$44.2K – 3896
2024
Q1 		$44.2K Buy
+22,100
New +$58.7K ﹤0.01% 3474
2023
Q1 		– Sell
-98,600
Closed -$138K – 3846
2022
Q4 		$138K Buy
+98,600
New +$141K ﹤0.01% 3275
2021
Q2 		– Sell
-310
Closed -$3K – 3926
2021
Q1 		$3K Buy
+310
New +$3.77K ﹤0.01% 4809
2019
Q4 		– Sell
-2,600
Closed -$4K – 4872
2019
Q3 		$4K Hold
2,600
– – ﹤0.01% 4575
2019
Q2 		$7K Hold
2,600
– – ﹤0.01% 4616
2019
Q1 		$10K Buy
2,600
+2,350
+940% +$8.4K ﹤0.01% 3869
2018
Q4 		$1K Sell
250
-63
-20% -$287 ﹤0.01% 4514
2018
Q3 		$2K Hold
313
– – ﹤0.01% 4332
2018
Q2 		$1K Hold
313
– – ﹤0.01% 4506
2018
Q1 		$8K Hold
313
– – ﹤0.01% 3816
2017
Q4 		$7K Hold
313
– – ﹤0.01% 3868
2017
Q3 		$16K Hold
313
– – ﹤0.01% 3580
2017
Q2 		$28K Buy
313
+34
+12% +$2.19K ﹤0.01% 3404
2017
Q1 		$23K Hold
279
– – ﹤0.01% 3324
2016
Q4 		$58K Hold
279
– – ﹤0.01% 3063
2016
Q3 		$90K Buy
279
+91
+48% +$33.2K ﹤0.01% 2838
2016
Q2 		$61K Sell
188
-4
-2% -$1.38K ﹤0.01% 2989
2016
Q1 		$64K Buy
192
+45
+31% +$15.3K ﹤0.01% 2953
2015
Q4 		$57K Sell
147
-66
-31% -$25.8K ﹤0.01% 2989
2015
Q3 		$87K Buy
213
+14
+7% +$7.33K ﹤0.01% 2691
2015
Q2 		$146K Buy
199
+123
+162% +$87.2K ﹤0.01% 2551
2015
Q1 		$37K Buy
76
+69
+986% +$29.4K ﹤0.01% 3036
2014
Q4 		$2K Hold
7
– – ﹤0.01% 3824
2014
Q3 		$2K Buy
+7
New +$2.1K ﹤0.01% 3902

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's CRDF Position: Q2 2024 in Review

Bank of Montreal sold out of Cardiff Oncology (CRDF) in Q2 2024, closing a stake of 22,100 shares — an estimated $44.2K sold.

Bank of Montreal first reported a position in CRDF in Q3 2014 and held it in 24 quarters. The position peaked at $146K in Q2 2015. 90 funds tracked by Wall St. Rank hold CRDF as of Q2 2024.

  • Bank of Montreal reported no remaining Cardiff Oncology position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 22,100 Cardiff Oncology shares in Q2 2024, an estimated $44.2K.
  • Bank of Montreal first reported a position in Cardiff Oncology in Q3 2014 and held it in 24 quarters.
  • Bank of Montreal's Cardiff Oncology position peaked at $146K in Q2 2015.
  • 90 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.